Quick Summary:
Delve into the dynamic world of pharmaceuticals with Elite Pharmaceuticals Inc - Financial and Strategic SWOT Analysis Review, a comprehensive report designed to illuminate the intricate operations, strategies, and key factors influencing this key player in the industry. Underpinned by a thorough SWOT analysis, this sector-specific report discloses the enterprise's strengths, weaknesses, potential opportunities and threats, providing invaluable insights for stakeholders, competitors, and potential investors.
As well as presenting a detailed description of the company's varied business divisions and their operations, the report provides descriptions of their product portfolio which includes drugs for bariatric, cardiovascular, allergy, and infection treatments. Additionally, the report elucidates Elite's use of its proprietary ART platform in drug manufacturing and development and shines a light on a pipeline of abuse-deterrent opioids for chronic pain treatment. Use this wealthy knowledge resource to formulate effective business strategies, understand your competitors, and identify key customers and partners better.
Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company that focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs upon marketing approvals via Abbreviated New Drug Applications (ANDA) and branded drugs via New Drug Application (NDA) for the treatment of cardiovascular disorders, allergies, infections, bariatric and others. Its key commercialized product portfolio include Adipex-P, Bontril for Bariatric therapy; Revia for Pain related; Dantrium for muscle relaxation; Adderall XR for central nervous system; Loxapine for Antipsychotic; among others. Elite also has a pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary ART (abuse-deterrent technology) platform to develop and manufacture oral, controlled-release drugs. Elite is headquartered in Northvale, New Jersey, the US.Elite Pharmaceuticals Inc Key Recent Developments
- Sep 25, 2023: Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
- Aug 28, 2023: Back to NewsroomBack to Newsroom Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
- Aug 14, 2023: Elite Pharmaceuticals, Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information
- Feb 15, 2023: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Mylan Laboratories Ltd
- Mallinckrodt LLC
- Collegium Pharmaceutical Inc
- Aurobindo Pharma USA Inc
- Sandoz Inc
- Teva Pharmaceuticals USA Inc
- Purdue Pharma LP
- Endo Pharmaceuticals Inc
- Acura Pharmaceuticals Inc
- Pfizer Inc